Sonoma Pharmaceuticals, Inc. 54445 Conestoga Court, Suite 150 Boulder, CO 80301 Attn: Amy Trombly, President & CEO Dear Ms. Trombly:At the Market Offering Agreement • February 24th, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations
Reference is made to the At The Market Offering Agreement, dated as of December 23, 2022 (the “ATM Agreement”), between Sonoma Pharmaceuticals, Inc. (the “Company”) and Ladenburg Thalmann & Co., Inc. (the “Ladenburg”). This letter (the “Amendment”) constitutes an agreement between the Company and Ladenburg to amend the ATM Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.
